Revvity, Inc. (LON:0KHE)

Market Cap	10.96B
Revenue (ttm)	2.19B
Net Income (ttm)	214.75M
Shares Out	n/a
EPS (ttm)	1.74
PE Ratio	51.03
Forward PE	n/a
Dividend	0.22 (0.19%)
Ex-Dividend Date	Apr 17, 2025

Volume	311
Average Volume	3,154
Open	115.65
Previous Close	113.30
Day's Range	115.20 - 116.17
52-Week Range	79.50 - 138.90
Beta	1.03
RSI	45.22
Earnings Date	Jan 30, 2025

About Revvity

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its pro...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1937
• Employees: 11,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KHE

Financial Performance

In 2024, Revvity's revenue was $2.76 billion, an increase of 0.16% compared to the previous year's $2.75 billion. Earnings were $270.39 million, a decrease of -60.99%.

Financial numbers in USD